The Canadian Cancer Research Conference 2019
by
K.J.C. Galpin
1,2,†,
D.P. Cook
1,2,†,
L.M. Salemi
3,
S. Urowitz
3,
C. Williams
4,
J.C. Bell
2,5,
M.D. Brundage
6 and
B.C. Vanderhyden
1,2,*
1
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada
2
Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
3
Canadian Cancer Research Alliance, Canadian Partnership Against Cancer, Toronto, ON, Canada
4
Ontario Institute for Cancer Research, Toronto, ON, Canada
5
Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada
6
Queen’s Cancer Research Institute, Department of Oncology, Queen’s University, Kingston, ON, Canada
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to the present work, with order determined by a coin flip.
Curr. Oncol. 2020, 27(2), 226-230; https://doi.org/10.3747/co.27.6245
Submission received: 10 February 2020
/
Revised: 8 March 2020
/
Accepted: 5 April 2020
/
Published: 1 May 2020
Abstract
The 5th Canadian Cancer Research Conference (ccrc) took place 3–5 November 2019 in Ottawa, Ontario. Nearly 1000 participants—scientists, oncologists, community members, and patients—gathered to share knowledge, foster collaboration, and fuel the future of cancer research in Canada. The scientific program included 3 plenary sessions, 26 concurrent sessions, and 2 poster sessions presenting research described in more than 600 submitted abstracts, giving participants the opportunity to share health research that collectively encompassed the 4 pillars recognized by the Canadian Institutes of Health Research. In addition to the breadth of topics addressed by Canadian and international experts, the highlights of the meeting included the integration of patients and patient advocates, new rapid-fire sessions for abstract presentation, and events that enhanced learning opportunities for trainees.
Keywords:
cancer research; patient engagement; meetings
Share and Cite
MDPI and ACS Style
Galpin, K.J.C.; Cook, D.P.; Salemi, L.M.; Urowitz, S.; Williams, C.; Bell, J.C.; Brundage, M.D.; Vanderhyden, B.C. The Canadian Cancer Research Conference 2019. Curr. Oncol. 2020, 27, 226-230. https://doi.org/10.3747/co.27.6245
AMA Style
Galpin KJC, Cook DP, Salemi LM, Urowitz S, Williams C, Bell JC, Brundage MD, Vanderhyden BC. The Canadian Cancer Research Conference 2019. Current Oncology. 2020; 27(2):226-230. https://doi.org/10.3747/co.27.6245
Chicago/Turabian StyleGalpin, K.J.C., D.P. Cook, L.M. Salemi, S. Urowitz, C. Williams, J.C. Bell, M.D. Brundage, and B.C. Vanderhyden. 2020. "The Canadian Cancer Research Conference 2019" Current Oncology 27, no. 2: 226-230. https://doi.org/10.3747/co.27.6245
